Instil Bio Inc. Cash Flow-to-Debt Ratio
Instil Bio Inc. cash flow-to-debt ratio. Instil Bio Inc. (TIL) has a Cash Flow-to-Debt Ratio of -0.01x as of March 2026, meaning its operating cash flow of $-1.34 Million could theoretically repay 0% of its total liabilities ($89.73 Million) in one year. See financial flexibility index of Instil Bio Inc. to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Instil Bio Inc. (2019–2025)
Cash flow-to-debt ratio of Instil Bio Inc. from 2019 to 2025. Historical debt coverage capacity for Instil Bio Inc. across 7 annual periods. Also explore Instil Bio Inc. (TIL) equity growth momentum to track the company's year-over-year net asset growth rate.
Instil Bio Inc. Cash Flow-to-Debt Ratio by Year (2019–2025)
Instil Bio Inc. cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Instil Bio Inc.. For the full cash flow conversion analysis, see TIL cash flow metrics.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.41x | $-36.62 Million | $89.66 Million | ▲ +31.0% |
| 2024 | -0.59x | $-55.70 Million | $94.13 Million | ▲ +28.0% |
| 2023 | -0.82x | $-82.03 Million | $99.80 Million | ▲ +45.9% |
| 2022 | -1.52x | $-180.16 Million | $118.52 Million | ▲ +31.8% |
| 2021 | -2.23x | $-122.14 Million | $54.78 Million | ▼ -100.6% |
| 2020 | -1.11x | $-29.62 Million | $26.64 Million | ▲ +70.2% |
| 2019 | -3.73x | $-5.29 Million | $1.42 Million | — |